Originally recorded on September 9, 2021
Join our panel of experts as they discuss new treatments available for dogs diagnosed with osteosarcoma and their families in an educational, interactive webinar. This webinar includes a dynamic discussion between Dr. Brooke Fowler, DVM, MS, DACVIM (Oncology), ELIAS Chief Medical Officer Dr. Noe Reyes, Director of Patient Management Jody Ehrhardt, and CEO Tammie Wahaus, as well as attendee polling and live Q&A. Take advantage of this opportunity to arm yourself with the most current information about the treatment of canine cancers to share with your clients.
 |
Brooke Fowler, DVM, MS, DACVIM (Oncology)Veterinary Oncologist, Aspen Meadow Veterinary SpecialistsDr. Fowler is a veterinary oncologist at Aspen Meadow Veterinary Specialists in Longmont, Colorado. She completed her undergraduate education at the University of Michigan in Ann Arbor, and earned her Doctor of Veterinary Medicine degree at the University of Illinois in Champaign, Illinois. Dr. Fowler then completed a rotating internship at a private practice in Chicago, as well as an oncology internship and three-year residency at the University of Missouri. During her residency, she obtained a master’s degree with a special focus on the immune system as it relates to cancer. Dr. Fowler participated in the recent ELIAS Animal Health canine osteosarcoma clinical trial and is excited to share her experience and insights from the study. |
 |
Noe Reyes, DVMChief Medical Officer, ELIAS Animal HealthAs Chief Medical Officer for ELIAS Animal Health, Dr. Reyes brings extensive experience as both a veterinarian and animal health researcher. He has served as Chief Medical Officer of ELIAS since its founding in 2015. Dr. Reyes is a graduate of the University of California, Davis (BS, DVM). |
 |
Jody EhrhardtDirector of Clinical Trials and Patient ManagementAs Director of Patient Management for ELIAS Animal Health, Jody Ehrhardt leverages her 20+ years of experience in human and animal clinical trials to oversee the company's clinical research and manage and support participating clinical and commercial hospitals. |
 |
Tammie WahausChief Executive Officer, ELIAS Animal HealthAs Founder, Chief Executive Officer and Board Chair, Ms. Wahaus has led the strategic planning, business development, manufacturing, regulatory and clinical trial activities of the company since 2014. Ms. Wahaus has more than twenty-five years of experience serving in key leadership roles in public and private companies. She joined TVAX Biomedical (an affiliate) in 2012 as Chief Financial Officer and was responsible for developing the animal health business strategy which was then spun off as ELIAS Animal Health. |